The weekly litigation news digest is live. Subscribe now

IP Verse

Novel Compounds Having Inhibitory Activity Against Sodium-Dependant Glucose Transporter - EP2896397

The patent EP2896397 was granted to Mitsubishi Tanabe Pharma on Oct 7, 2020. The application was filed on Jul 30, 2004 under application number EP14194507A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2896397

MITSUBISHI TANABE PHARMA
Application Number
EP14194507A
Filing Date
Jul 30, 2004
Status
Patent Maintained As Amended
Sep 4, 2020
Publication Date
Oct 7, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GALENICUM HEALTH SLJun 6, 2018TORREJON NIETOADMISSIBLE
GENERICS UKJun 5, 2018ELKINGTON AND FIFEADMISSIBLE

Patent Citations (20) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0355750
DESCRIPTIONJP2000034230
DESCRIPTIONJP2000034239
DESCRIPTIONJPH09263549
DESCRIPTIONJPH10324632
DESCRIPTIONJPS63233975
DESCRIPTIONUS6515117
DESCRIPTIONWO0074681
DESCRIPTIONWO0127128
DESCRIPTIONWO02070020
DESCRIPTIONWO02094262
DESCRIPTIONWO9725033
OPPOSITIONEP1609785
OPPOSITIONGB2359554
OPPOSITIONUS2003114390
OPPOSITIONWO0127128
SEARCHEP1609785
SEARCHGB2359554
SEARCHUS2003114390
SEARCHWO2004080990

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents